These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33120888)

  • 1. LC-MS/MS Determination of Modified Nucleosides in The Urine of Parkinson's Disease and Parkinsonian Syndromes Patients.
    Gątarek P; Kałużna-Czaplińska J; Pawełczyk M; Jastrzębski K; Giebułtowicz J; Głąbiński A; Bobrowska-Korczak B
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33120888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced levels of modified nucleosides in the urine of autistic children. Preliminary studies.
    Bobrowska-Korczak B; Gątarek P; Rosiak A; Giebułtowicz J; Kałużna-Czaplińska J
    Anal Biochem; 2019 Apr; 571():62-67. PubMed ID: 30771338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a rapid LC-MS/MS method for determination of methylated nucleosides and nucleobases in urine.
    Raćkowska E; Bobrowska-Korczak B; Giebułtowicz J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Oct; 1128():121775. PubMed ID: 31493699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation and identification of purine nucleosides in the urine of patients with malignant cancer by reverse phase liquid chromatography/electrospray tandem mass spectrometry.
    Li HY; Wang SM; Liu HM; Bu SS; Li J; Han D; Zhang MZ; Wu GY
    J Mass Spectrom; 2009 May; 44(5):641-51. PubMed ID: 19142897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of modified nucleosides in the urine of children with autism spectrum disorder.
    Osredkar J; Kumer K; Fabjan T; Jekovec Vrhovšek M; Maček J; Zupan M; Bobrowska-Korczak B; Gątarek P; Rosiak A; Giebułtowicz J; Bjørklund G; Chirumbolo S; Kałużna-Czaplińska J
    Acta Biochim Pol; 2023 May; 70(2):335-342. PubMed ID: 37130262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Genistein Supplementation on the Progression of Neoplasms and the Level of the Modified Nucleosides in Rats With Mammary Cancer.
    Banys K; Giebultowicz J; Sobczak M; Wyrebiak R; Bielecki W; Wrzesien R; Bobrowska-Korczak B
    In Vivo; 2021; 35(4):2059-2072. PubMed ID: 34182481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
    Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling of a wide range of neurochemicals in human urine by very-high-performance liquid chromatography-tandem mass spectrometry combined with in situ selective derivatization.
    Lee W; Park NH; Ahn TB; Chung BC; Hong J
    J Chromatogr A; 2017 Dec; 1526():47-57. PubMed ID: 29031967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, validation and application of a fast analytical methodology for the simultaneous determination of DNA- and RNA-derived urinary nucleosides by liquid chromatography coupled to tandem mass spectrometry.
    Rodríguez-Gonzalo E; Herrero-Herrero L; García-Gómez D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1019():132-9. PubMed ID: 26565068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of urinary methylated nucleosides of patients with coronary artery disease by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Li Y; Yu H; Zhao W; Xu X; Zhou J; Xu M; Gao W; Yuan G
    Rapid Commun Mass Spectrom; 2014 Oct; 28(19):2054-8. PubMed ID: 25156594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frequency and clinical profile of Parkinson's disease and other Parkinsonian syndromes seen in the Department of Neurology at the Befelatanana Hospital Antananarivo].
    Rasaholiarison NF; Razafimahefa J; Rakotomanana JL; Tehindrazanarivelo AD
    Pan Afr Med J; 2019; 33():229. PubMed ID: 31692664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring urinary modified nucleosides as biomarkers for diabetic retinopathy: Development and validation of a ultra performance liquid chromatography-tandem mass spectrometry method.
    Yao C; Lv D; Zhou X; Fu P; Sun W; Chen J; Lin H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jan; 1232():123968. PubMed ID: 38150972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS-based urinary metabolite signatures in idiopathic Parkinson's disease.
    Luan H; Liu LF; Meng N; Tang Z; Chua KK; Chen LL; Song JX; Mok VC; Xie LX; Li M; Cai Z
    J Proteome Res; 2015 Jan; 14(1):467-78. PubMed ID: 25271123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.
    Cannas A; Solla P; Borghero G; Floris GL; Chio A; Mascia MM; Modugno N; Muroni A; Orofino G; Di Stefano F; Calvo A; Moglia C; Restagno G; Meloni M; Farris R; Ciaccio D; Puddu R; Vacca MI; Melis R; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Marrosu MG; Marrosu F
    J Neurol; 2015 Nov; 262(11):2498-503. PubMed ID: 26275564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HILIC-MS/MS for the Determination of Methylated Adenine Nucleosides in Human Urine.
    Guo C; Hu Y; Cao X; Wang Y
    Anal Chem; 2021 Dec; 93(51):17060-17068. PubMed ID: 34902250
    [No Abstract]   [Full Text] [Related]  

  • 16. Simultaneous Determination of Methylated Nucleosides by HILIC-MS/MS Revealed Their Alterations in Urine from Breast Cancer Patients.
    Fang Z; Hu Y; Hong X; Zhang X; Pan T; Pan C; Zheng S; Guo C
    Metabolites; 2022 Oct; 12(10):. PubMed ID: 36295875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of urinary nucleosides. IV. Identification of urinary purine nucleosides by liquid chromatography/electrospray mass spectrometry.
    Dudley E; Lemière F; Van Dongen W; Tuytten R; El-Sharkawi S; Brenton AG; Esmans EL; Newton RP
    Rapid Commun Mass Spectrom; 2004; 18(22):2730-8. PubMed ID: 15499664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using UHPLC Q-Trap/MS as a complementary technique to in-depth mine UPLC Q-TOF/MS data for identifying modified nucleosides in urine.
    Lu Z; Wang Q; Wang M; Fu S; Zhang Q; Zhang Z; Zhao H; Liu Y; Huang Z; Xie Z; Yu H; Gao X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Apr; 1051():108-117. PubMed ID: 28340480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased urinary level of oxidized nucleosides in patients with mild-to-moderate Alzheimer's disease.
    Lee SH; Kim I; Chung BC
    Clin Biochem; 2007 Sep; 40(13-14):936-8. PubMed ID: 17692303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted metabolomics: Liquid chromatography coupled to mass spectrometry method development and validation for the identification and quantitation of modified nucleosides as putative cancer biomarkers.
    Godoy AT; Eberlin MN; Simionato AVC
    Talanta; 2020 Apr; 210():120640. PubMed ID: 31987192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.